Once patients develop subclinical cardiovascular disease overlapping with CKM risk factors, they are in stage 3, and they are in stage 4 once they have clinical cardiovascular disease overlapping with CKM risk factors [35,36]. The gene discussed is CKM; the disease is cardiovascular disorder.